Research Article
The “CROMa” Project: A Care Pathway for Clinical Management of Patients with Bisphosphonate Exposure
Table 5
Logistic regression model (forward stepwise procedure) for BRONJ presence, stratified for gender.
(a) Male |
| Variable | OR | Robust (SE) | | 95% CI |
| Behavioral habits | .92 | .15 |
0.62 | 1.07–1.39 | Therapy intervals | 3.14 | 1.01 | <.01 | 1.68–5.89 |
|
|
Number of observations= 61; log likelihood= −13.27; = 24.50; value < .01.
|
(b) Female |
| Variable | OR | Robust (SE) | | 95% CI |
| Behavioral habits | 1.22 | .08 |
<.01 | 1.07–1.39 | Oncology bone disease | 17.90 | 14.03 | <.01 | 3.85–83.25 | Therapy regimen | 2.85 | 1.41 | .03 | 1.08–7.50 | Therapy intervals | 2.37 | .73 | <.01 | 1.29–4.32 |
|
|
Number of observations= 403; log likelihood= −60.03; = 33.10; value < .01.
|